News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
10,116 Results
Type
Article (277)
Company Profile (1)
Press Release (9838)
Section
Business (3085)
Career Advice (41)
Deals (449)
Drug Development (926)
Employer Resources (5)
FDA (198)
Job Trends (237)
News (4775)
Policy (359)
Tag
Academia (61)
Allergies (1)
Alliances (1084)
ALS (1)
Alzheimer's disease (25)
Approvals (201)
Artificial intelligence (9)
Autoimmune disease (2)
Automation (1)
Best Places to Work (202)
Biosimilars (2)
Biotechnology (1)
Breast cancer (4)
Cancer (37)
Cardiovascular disease (15)
Career advice (36)
CAR-T (2)
Cell therapy (11)
Cervical cancer (1)
Clinical research (825)
Collaboration (21)
Compensation (1)
COVID-19 (14)
CRISPR (1)
C-suite (6)
Data (53)
Depression (2)
Diabetes (7)
Diagnostics (166)
Digital health (1)
Diversity, equity & inclusion (2)
Drug discovery (2)
Duchenne muscular dystrophy (1)
Earnings (766)
Employer branding (2)
Employer resources (5)
Events (1259)
Executive appointments (20)
FDA (225)
Funding (13)
Gene editing (1)
Gene therapy (4)
GLP-1 (5)
Government (35)
Guidances (1)
Healthcare (358)
Immunology and inflammation (2)
Indications (3)
Infectious disease (17)
Inflammatory bowel disease (4)
Intellectual property (5)
Interviews (4)
IPO (153)
Job creations (40)
Job search strategy (33)
Layoffs (3)
Legal (61)
Lung cancer (4)
Lymphoma (1)
Manufacturing (15)
Medical device (295)
Medtech (295)
Mergers & acquisitions (311)
Metabolic disorders (8)
Multiple sclerosis (1)
Neuroscience (35)
NextGen: Class of 2025 (161)
Non-profit (85)
Obesity (1)
Opinion (5)
Pain (3)
Parkinson's disease (3)
Patents (13)
Patient recruitment (2)
People (998)
Phase I (258)
Phase II (327)
Phase III (288)
Pipeline (32)
Policy (4)
Postmarket research (24)
Preclinical (105)
Press Release (10)
Prostate cancer (1)
Radiopharmaceuticals (12)
Rare diseases (4)
Real estate (155)
Recruiting (1)
Regulatory (287)
Reports (10)
Research institute (95)
Resumes & cover letters (9)
Series A (3)
Spinal muscular atrophy (6)
Startups (55)
Supply chain (2)
Vaccines (5)
Women's health (1)
Date
Last 7 days (17)
Last 30 days (49)
Last 365 days (1092)
2025 (333)
2024 (1082)
2023 (766)
2022 (732)
2021 (727)
2020 (848)
2019 (779)
2018 (635)
2017 (475)
2016 (420)
2015 (504)
2014 (379)
2013 (306)
2012 (345)
2011 (282)
2010 (270)
Location
Africa (13)
Alabama (2)
Arizona (3)
Arkansas (1)
Asia (599)
Australia (132)
California (93)
Canada (24)
China (12)
Colorado (10)
Connecticut (4)
Delaware (1)
Europe (1386)
Florida (67)
Georgia (2)
Idaho (1)
Illinois (4)
Indiana (1)
Japan (5)
Kansas (4)
Louisiana (1)
Maryland (8)
Massachusetts (96)
Michigan (1)
Minnesota (2)
Missouri (2)
Nebraska (1)
New Hampshire (1)
New Jersey (74)
New Mexico (1)
New York (70)
North Carolina (16)
Northern California (36)
Ohio (7)
Oklahoma (2)
Oregon (1)
Pennsylvania (54)
South America (15)
South Carolina (2)
Southern California (38)
Tennessee (1)
Texas (30)
United States (548)
Utah (4)
Virginia (3)
Washington State (4)
West Virginia (2)
Wisconsin (1)
10,116 Results for "encompass".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Encompass Health to present at 2024 Leerink Partners Healthcare Crossroads Conference
Encompass Health Corp. (NYSE: EHC) today announced it will participate in the 2024 Leerink Partners Healthcare Crossroads Conference being held in Austin, Texas, May 28-30, 2024.
May 23, 2024
·
1 min read
Press Releases
AtriCure Receives CE-Mark for the EnCompass® Clamp
October 1, 2024
·
3 min read
Business
Encompass Health reports results for second quarter 2024
August 5, 2024
·
26 min read
Press Releases
Encompass Health increases and declares dividend on common stock and announces increase in common stock repurchase authorization
July 24, 2024
·
3 min read
EnCompass receives FDA conditional IDE approval to commence a US pilot study of its F2 cerebral embolic protection (CEP) system in patients undergoing transcatheter aortic valve replacement (TAVR)
EnCompass Technologies, Inc. announced the US Food and Drug Administration (FDA) officially granted conditional Investigational Device Exemption (IDE) approval for its F2 cerebral embolic protection system on Friday, September 22, 2023.
September 27, 2023
·
3 min read
Encompass Health to present at Barclays Global Healthcare Conference - March 6, 2023
Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Barclays Global Healthcare Conference, which is being held in Miami, Florida , on March 14-16, 2023.
March 6, 2023
·
1 min read
BioMidwest
World’s First Use of EnCompass Medical Device to Protect Against Brain Injury Achieved at the Israeli-Georgian Medical Research Clinic, Tbilisi, Georgia
EnCompass Technologies, Inc. announced its novel F2 cerebral embolic filter was used successfully in three transcatheter aortic valve replacement procedures on April 29th and 30th at the Israeli-Georgian Medical Research Clinic, Tbilisi, Georgia.
May 23, 2023
·
3 min read
Business
Encompass Health announces date of 2022 third quarter earnings call
Encompass Health Corp. announced it will report results for its third quarter ended Sept. 30, 2022, after the market closes on Oct. 26, 2022.
September 29, 2022
·
1 min read
Business
Encompass Health reports results for second quarter 2022
Encompass Health Corporation, the largest owner and operator of inpatient rehabilitation hospitals in the United States, reported its results of operations for the second quarter ended June 30, 2022 and affirmed its 2022 guidance.
August 1, 2022
·
15 min read
BioMidwest
AtriCure Launches EnCompass® Clamp, a part of Isolator Synergy™ Ablation System
AtriCure Launches EnCompass ® Clamp, a part of Isolator Synergy™ Ablation System.
April 12, 2022
·
2 min read
1 of 1,012
Next
